SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

JUBILANT PHARMOVA

BSE: 530019 31 Jul 2025
Healthcare
₹ 1197.1
JUBILANT PHARMOVA LIMITED specializes in Pharmaceuticals within the Healthcare sector.

JUBILANT PHARMOVA - Share Price & Details

Market Cap
₹19,562
High /Low
1,310 / 734.0
Stock P/E
40.5
Book Value
₹393.0
Dividend Yield
0.43
ROCE
9.54
ROE
₹9.5
Face Value
1.0
PEG Ratio
3.99
EVEBITDA
₹16.8
Debt
2,731
CMP / FCF
-649.0
Debt to equity
₹0.44
NP Ann
836
High price all time
1,310
Piotroski score
₹7.0
Graham Number
505.0
No. Eq. Shares
15.9
Net CF
₹107
Net profit
457
Price to book value
3.14
Interest Coverage
₹4.08
Low price all time
58.0
Industry PE
34.0
Reserves
₹6,239
Free Cash Flow
₹-38.5

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.4691.0
Triochem Products Ltd.,3.25-4.52NA-18.440
530019602.058.0595.00.2619,56240.5
Concord Biotech Limited4,392.681,419.384,298.8413.571905051.3
NEULAND LABORATORIES LTD.3,358.24277.343,283.6021.621779485.4

Peer Comparison Chart


About JUBILANT PHARMOVA

JUBILANT PHARMOVA LIMITED, with Security Code 530019, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

jubilant pharma revenue grows 9percent yoy to rs 1879 crore

(30 Jul 2025)
JUBILANT PHARMOVA REVENUES GREW ~9% YOY TO ₹1879 CRORE MAJORLY DRIVEN BY CDMO STERILE INJECTABLES(14% GROWTH) AND DRUG DISCOVERY SERVICES(42% GROWTH).
Read more →

Jubilant Pharmo Consolidated June 2025 Net Sales at Rs 1,900.70 crore, up 9.76% Y-o-Y

(30 Jul 2025)
Net Sales at Rs 1,900.70 crore in June 2025 up 9.76% from Rs. 1,731.70 crore in June 2024. Story continues below Advertisement.
Read more →

Jubilant Pharmova clocks nearly 79 pc drop in net profit to Rs 103 crore

(29 Jul 2025)
Mumbai, July 29 (IANS) Jubilant Pharmova Limited on Tuesday reported a sharp fall of 78.6 per cent in its net profit to Rs 103 crore for the...
Read more →

Jubilant Pharmova Q1 Results: Net profit slumps on high base, shares fall

(29 Jul 2025)
Jubilant Pharmova Ltd on Tuesday reported a sharp fall in first-quarter profit on a high base from last year, even as revenue and operating...
Read more →

Jubilant Pharmova consolidated net profit declines 78.66% in the June 2025 quarter

(29 Jul 2025)
Net profit of Jubilant Pharmova declined 78.66% to Rs 102.90 crore in the quarter ended June 2025 as against Rs 482.10 crore during the previous quarter...
Read more →

Sunil Singhania-owned Abakkus trims stakes in Jubilant Pharmova, Ion Exchange: Check the top ten holdings

(29 Jul 2025)
As of the June 2025 quarter, Singhania's Abakkus Fund holds 19 stocks with a combined market value of Rs 2690 crore, up from Rs 2510 crore...
Read more →

Company Updates